Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses
According to the Center for Disease Control and Prevention (CDC), the coronavirus disease 2019, a respiratory viral illness linked to significant morbidity, mortality, production loss, and severe economic depression, was the third-largest cause of death in 2020. Respiratory viruses such as influenza...
Enregistré dans:
Auteurs principaux: | Mahdi Ftouh, Nesrine Kalboussi, Nabil Abid, Souad Sfar, Nathalie Mignet, Badr Bahloul |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Hindawi Limited
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/18de53fd7fc94969a3149e1c5c1668a2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Progress in antiretroviral drug delivery using nanotechnology
par: Rama Mallipeddi, et autres
Publié: (2010) -
Yeasts in nanotechnology-enabled oral vaccine and gene delivery
par: Elena Ivanova
Publié: (2021) -
Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye
par: Alexander Vaneev, et autres
Publié: (2021) -
Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration
par: Gu W, et autres
Publié: (2013) -
Nanotechnology, from quantum mechanical calculations up to drug delivery
par: Szefler B
Publié: (2018)